Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine in India.

Earlier on Monday, the company had said that it remained committed to bringing its single-dose Covid-19 vaccine to India and looks forward to ongoing discussions with the Indian government.